AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

NCT00265876 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

NETWORK

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: AZD0530
DRUG: gemcitabine hydrochloride

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]